Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.080
+0.050 (4.85%)
At close: Mar 9, 2026, 4:00 PM EDT
1.090
+0.010 (0.93%)
After-hours: Mar 9, 2026, 7:55 PM EDT
Cognition Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 95 | 29 | 59 | 61 | 139 | - | |
| Market Cap Growth | 276.41% | -50.97% | -2.39% | -56.29% | - | - | |
| Enterprise Value | 51 | 8 | 27 | 15 | 216 | - | |
| Last Close Price | 1.03 | 0.70 | 1.85 | 2.10 | 6.32 | - | |
| PB Ratio | 2.49 | 1.55 | 2.43 | 1.51 | 2.72 | - | |
| P/TBV Ratio | 2.46 | 1.55 | 2.43 | 1.51 | 2.72 | - | |
| Debt / Equity Ratio | 0.01 | 0.04 | 0.05 | 0.04 | - | -1.00 | |
| Net Debt / Equity Ratio | -1.07 | -1.29 | -1.17 | -1.00 | -1.07 | -0.60 | |
| Net Debt / EBITDA Ratio | 0.87 | 0.45 | 0.57 | 0.92 | 1.92 | -0.44 | |
| Net Debt / FCF Ratio | 1.32 | 0.85 | 1.77 | 2.14 | 14.96 | -2.23 | |
| Quick Ratio | 6.20 | 2.49 | 3.07 | 5.80 | 7.25 | 1.95 | |
| Current Ratio | 6.45 | 2.65 | 3.37 | 6.11 | 7.50 | 2.13 | |
| Return on Equity (ROE) | -109.73% | -157.19% | -79.69% | -46.76% | -60.93% | - | |
| Return on Assets (ROA) | -78.99% | -103.15% | -74.08% | -49.69% | -53.95% | -149.26% | |
| Return on Capital Employed (ROCE) | -122.10% | -282.70% | -202.90% | -102.20% | -55.80% | -449.90% | |
| Earnings Yield | -31.08% | -116.59% | -43.40% | -35.15% | -8.41% | - | |
| FCF Yield | -32.80% | -97.74% | -27.20% | -30.72% | -2.63% | - | |
| Buyback Yield / Dilution | -70.13% | -32.31% | -27.03% | -355.42% | -921.60% | -8.18% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.